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INTRODUCTION
Recent research showed radiation for breast
cancer can increase heart risks (1, 2). In Ref.
(2), it has been noted that for every Gy of
radiation a women’s heart risk rises 7.4%.
However, the correlation between radia-
tion dose and heart tissue damage is still
an open problem. A more accurate model
of heart damage will significantly improve
the heart safety for patients underwent
radiotherapy.
Modern radiation treatment planning
systems (TPS) use computed tomography
(CT) images for dose calculation and eval-
uation. For evaluation of heart toxicity
from radiotherapy, the dose-volume his-
togram (DVH), which is generated by over-
lying radiation dose distribution on heart
delineations in CT images, is widely used.
However, there are three major factors that
deteriorate the accuracy of TPS-calculated
heart dose distribution. First conventional
CT is a fundamentally static imaging
modality without the capability to cap-
ture and depict the cardiac motion. Instead,
heart is usually blurred in CT images due
to the motion artifacts. Second, without
special contrast dye, CT provides limited
contrast between blood in heart chambers
and the surrounding myocardium. The
heart region in TPS is actually a mixture
of myocardium and blood, although only
the radiation dose to the myocardium is
accountable for heart risks. Finally, there
is significant intra- and inter-fractional
heart motion. As heart beats involuntarily
during and between radiation treatments,
myocardium deforms and moves non-
rigidly against the fixed radiation beam so
that the static dose distribution calculated
in CT based TPS does not reflect the accu-
rate radiation dose distribution in heart.
There is also concern on the choice
of the heart function for the evaluation
of radiation damage. Based on radiation
beam geometry, only part of the heart
will receive clinically significant level of
radiation during breast cancer treatment.
It is possible that the global heart func-
tion remains stable temporarily while cells
in the irradiated part of the myocardium
lose part or all of their functions. In this
case, regional heart function, which can be
derived from regional heart wall motion
and strain analysis, is a better indication of
heart damage corresponding to radiation
dose.
Although cardiac MRI is widely used
in radiology for the diagnosis of heart
disease, its application in radiation treat-
ment planning is limited. For multiple rea-
sons, it is not practical to use MRI directly
for radiation treatment planning of breast
cancer patients. However, via multimodal-
ity deformable image registration (DIR)
between MRI and CT, MRI images may
play a more critical role in the evaluation
of the heart damage from whole breast
radiation.
Tagged MRI (tMRI) (3) is a relatively
new imaging protocol that has been imple-
mented in the detection and diagnosis of
regional heart functional loss. tMRI meth-
ods record regional heart wall motion
information as they create identifiable
landmark bands (tags) in the myocardium
to establish dense point to point cor-
respondence between images. ECG-gated
tMRI image sets can be acquired at dif-
ferent phases of the cardiac cycle using
the corresponding pulse sequence. The 4D
(3D plus time) cardiac motion model can
be retrieved by image registration between
tMRIs at different phases.
In the following sessions, we use tMRI as
an example to explain how additional heart
function information in MRI is retrieved.
It is our objective to demonstrate the addi-
tional information retrieved from MRI can
help the evaluation and protection of heart
risks for breast cancer patients, and we
want to discuss the possibility of using MRI
to establish a more accurate correlation
between regional heart functional loss and
radiation dose.
METHOD
HEART MOTION UNCERTAINTY IN CT
First, we analyze the uncertainty in the CT
based TPS-calculated radiation dose distri-
bution of heart. The cardiac motion arti-
facts in CT acquisition has been previously
studied (4) so we focus on the uncertainty
related to the intra- and inter-fractional
cardiac motion and location variation.
We used kV fluoroscopy imaging
to monitor the intra-fractional cardiac
motion during breast cancer treatment
(experiment A). For a group of 10 left
breast cancer patients without breath hold-
ing or external breath suppression, fluo-
roscopy was acquired weekly at the gantry
angle of the treating beam for 15 s at
8 fps. The fluoroscopy radiation dose to the
patient was clinical insignificant.
To estimate the inter-fractional heart
location variation, we registered the weekly
CBCT of two t-spine patients (experiment
B). CBCT images were registered to match
the left breast and the variation of the heart
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location was evaluated by measuring the
average distance of the heart surface in the
registered image.
CARDIAC MOTION RETRIEVAL FROMMRI
For preliminary research purpose, we ret-
rospectively studied two sets of anony-
mous tMRI data acquired using the Spatial
Modulated Magnetization (SPAMM) pulse
sequence. Both tMRI sets were ECG-gated
and acquired at 24 phases during the car-
diac cycle. Each tMRI sets included three
long axis (LA) image sets (corresponding
to the two chamber, three chamber, and
four chamber view),a short axis (SA) image
set, and an ECG-gated non-tMRI image set
acquired at the end of diastole. The slice
thickness of SA tMRI was 5 mm. The spac-
ing between tags was 8 mm. There were
both horizontal and vertical tags in the
image.
Given tMRI and the corresponding
CT images of the breast cancer patient,
the work flow to estimate the correlation
between radiation dose and regional heart
functional loss is illustrated in Figure 1.
The tMRI images went through pre-
processing first to remove the intensity
non-uniformity introduced by the surface
coils used in the MRI process, and to reduce
the impact of the decay of image inten-
sity between different phases of the cardiac
cycle.
The epi- and endo-myocardial con-
tours were generated from tMRI using fre-
quency domain analysis. The modulated
tags corresponded to high frequency com-
ponents in the frequency domain and can
be effectively removed from the image
using frequency filtering. We segmented
the myocardium automatically in the SA
image using the method in Ref. (5). The
myocardium contours could be automat-
ically or manually generated in the LA
images.
There were multiple means to track the
movement of the tags during the cardiac
cycle, such as active contours (6), B-Spline
(7), physics deformable models (8), and
meshless deformable model (9).
The reconstructed cardiac motion
model had two uses. First, the myocardial
strain distribution was derived from the
myocardium motion, and the abnormality
in the distribution was used as the indica-
tion of local heart tissue damage. Second,
the cardiac model was integrated with the
CT-MRI image registration to calculate the
accumulative radiation dose distribution in
the myocardium during cardiac cycle. The
radiation dose to the blood was ignored, as
it would not directly cause heart risks.
Given the motion distribution, the
myocardial strain was computed as the
derivative of the displacement vectors at
image pixels. Strain depicted the variation
in motion between different parts of the
heart. Abnormalities (either high or low
value) in strain distribution reflected local
myocardial motion abnormalities, which
was a direct indication of regional heart
functional loss.
The CT-MRI image registration was
conducted to build a connection between
the TPS and the tMRI image domain.
First, we register CT to the end-of-diastole
non-tMRI using mutual information based
multimodality image fusion. The 4D heart
model (including both the cardiac motion
and the volumetric myocardium model) in
the MRI with regard to the beam geome-
try in the CT images was determined after
the registration. In the next step, we accu-
mulated the myocardial dose distribution
FIGURE 1 |The work flow of the cardiac motion tracking and myocardium dose evaluation method. The part encircled by the dashed line is the current
CT based heart dose calculation and evaluation in the treatment planning system.
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at different cardiac phases to reconstruct
the cardiac-motion-adjusted accumulative
myocardium dose distribution. The final
step was to align the strain distribution
to the motion adjusted dose distribution.
The correlation between the strain and
radiation dose was calculated to enable
us to establish the radiation-dose-to-heart-
risk model in future research.
DISCUSSION
The uncertainty in the TPS dose distribu-
tion caused by CT imaging was not con-
sidered explicitly in previous studies. The
cardiac motion artifacts in CT imaging
can be reduced after using modern tech-
nology such as the multi-detector com-
puted tomography (MDCT), however cur-
rently the high cost limited wide use of
such techniques at radiation oncology clin-
ics. The low blood-to-tissue contrast in
CT can be increased by injecting contrast
dye during patient simulation, although
this requires longer preparation time and
the improvement is limited if the imag-
ing motion artifact was not well addressed.
Based on experiment A, the average
infra-fractional motion of the heart wall,
as projected to the beam eye view in
kV fluoroscopy, was 1.3± 0.3 cm. Aver-
age inter-fractional heart location varia-
tion can be as much as 1.5 cm as mea-
sured in the CBCT images acquired in
experiment B.
To address the uncertainties in heart
location and the corresponding dose dis-
tribution, we proposed to use MRI in the
evaluation of heart risks for breast cancer
patients. As demonstrated by the tMRI-
based cardiac analysis framework, MRI
had less motion artifacts, higher blood-to-
tissue contrast (by using appropriate pulse
sequence), and provided infra-fractional
cardiac motion information.
The accuracy of the MRI-based cardiac
analysis was determined by the accuracy
of fundamental image processing modules
such as registration, segmentation, and
motion tracking. Multimodality image
registration between CT and MRI was
a well-studied problem and commercial
software is now available to generate sat-
isfactory registration results. However,
it should be noted that the couch top
used in radiation oncology CT simulator,
and diagnosis MRI, were different. A DIR
should be conducted to correct for the
variation of anatomy caused by different
couch tops. It was also critical that the
registration should align the surface mark-
ers in the CT and MRI images since they
determined the radiation beam geometry
in breast cancer radiation treatment. Effec-
tive approaches to automatically delineate
the myocardium and to derive the strain
from MRI images have been proposed in
previous studies. The image registration
and motion tracking uncertainties have
been discussed in previous research efforts
(9, 10). The overall uncertainty in the pro-
posed methodology also depended on the
interpolation and extrapolation error dur-
ing the projection process to transfer the
displacement and the radiation dose distri-
bution between different image domains.
Interpolation and extrapolation errors
were hard to quantify or validate directly.
We can use the inverse minimization proce-
dure to reduce the error, at the cost of extra
processing time.
The major technical challenge in MRI-
based heart risk analysis was the recon-
struction of the cardiac-motion-adjusted
accumulative radiation dose distribution.
To get the accumulative dose, one needed
to deform the original CT image to regen-
erate CT images at different cardiac phases
using the cardiac motion derived from
the tMRI images. The difficulty increased
as the CT and the tMRI imaging planes
were not the same and intersected each
other at oblique angles. The accuracy
of the regenerated CT images needed
further validation before using for dose
recalculation.
Given adequate information, a polyno-
mial fit can be generated to describe the
correlation between regional heart func-
tion loss and the radiation dose. The fitted
model can be used to quantitatively esti-
mate the heart risk based on accumulative
radiation dose.
Finally, it should be noted that although
the motion adjusted radiation dose distri-
bution is more accurate and specific than
the currently used heart DVH in treat-
ment planning CT, it was still an approx-
imation to the actual dose distribution.
The method we proposed did not con-
sider inter-fractional heart location vari-
ation and the impact of respiration on
heart location. Moreover, the patient heart
beat pattern may change during the course
of radiation treatment. All these factors
caused extra uncertainties in the calculated
accumulative myocardium dose.
CONCLUSION
We discussed the uncertainties of using
CT calculated dose to evaluate the radia-
tion damage to the heart. To improve the
quality of heart risk analysis for breast can-
cer patients, we proposed a tMRI-based
framework to derive the cardiac motion,
the myocardium strain, and eventually the
regional heart function loss. The proposed
framework demonstrated the possibility
and technical challenge of establishing
a correlation between myocardium dam-
age and radiation dose for breast cancer
patients using MRI. By using MRI, regional
heart function loss could be detected and
the radiation dose can be adjusted by
generating the accumulative dose during
cardiac cycle. We plan to collect tMRI
data from more patients to improve the
accuracy, efficiency, and statistical robust-
ness of the proposed framework in future
studies.
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